OREANDA-NEWS. On 28 August 2008 was , that Pharmstandard announced its 1H 2008 achievements 
•   Leading domestic pharmaceutical company in Russia (measured by sales) 
     •     #2 pharma company overall in Russia by sales value in 1H 2008 
     •     #1 pharma company in the commercial segment by sales value in 1H 2008 
•   Industry leading growth and profitability 
     •     Revenue growth of 40% to RUR 6,198 mln (US\\$259 mln) in 1H 2008 
     •     EBITDA growth +62% and to RUR 2,621 mln (US\\$110 mln) in 1H 2008, EBITDA margin equals 42% 
     •     Net profit grew by 83% to RUR 1,757 mln (US\\$ 73 mln) 
•   Market leading brands and new products 
     •     7 brands among top-15 best selling domestic brands in Russia 
     •     Launched 8 new products 
•   Experienced sales force and modern and efficient manufacturing facilities 
     •     More than 445 sales force (hired more than 100 people) 
     •     Launched new workshop for capsules in Kursk 
     •     RUR 381 mln (US\\$ 16 mln) invested in modernisation of production facilities 
•   Consolidated interest in Ufa, Kursk and Tyumen subsidiaries up  to 99%, 97%, and 96% of shares